An official of the Maharashtra State Road Development Corporation (MSRDC) said the Pune-bound lane of the expressway will be shut for traffic from 12 pm to 2 pm for the erection of gantries at Amrutanjan Bridge and Khandala tunnel as part of the Highway Management System

Mumbai-Pune Expressway: 2-hour Block on Part of Road on Tuesday, Traffic Snarls Likely | Here’s Why - News18

Amrutanjan Healthcare, which earlier initiated a forensic audit on a whistleblower complaint, has informed exchanges that the audit has found few acts of personal gains by some of its employees including kickbacks from marketing vendors and malpractices in casual labour onboarding.

Deloitte finds malpractices in vendor management and casual labour onboarding by Amrutanjan employees

Amrutanjan offers buyback of 3.2 lakh shares at 30% premium, yielding 6.8-2.3% returns for eligible shareholders. Stock has declined 11% in last yr and trades at 50x FY23 earnings. Buyback open from July 19-25, small shareholders can claim 53,652 shares. Broader market optimism and run-up to buyback…

Amrutanjan Healthcare buyback: Should you tender your shares?

Amrutanjan Health Care on Friday announced that its board approved a buyback plan at an offer price of ₹900 per equity share, a 35 per cent premium over Wednesday’s closing price of ₹667.9 on NSE.

Amrutanjan Health Care board approves buyback plan at ₹900 per share

The stock that had been rangebound for the past four months saw a spike after the buyback announcement. It is now 9 percent away from its 52-week high level

Amrutanjan Healthcare spikes 14% after buyback announcement. Check out details

Amrutanjan stocks hit a 52-week high on August 12, 2022 at ₹847.25 per share, while it tested a 52-week low of ₹554.05 apiece on March 31, 2023

Amrutanjan Health Care shares rally 12 per cent on buyback proposal

Stocks that will see action on May 30, 2023, include ITC, Reliance Ind, Adani Ports, Amrutanjan, Apollo Hospitals, Coffee Day, Deccan Gold, GMDC, Banking Pharma, Suzlon, Reliance Infra, Torrent Pharma, L&T, PG Electroplast

Stocks that will see action today (May 30, 2023)

The company shall also file the final report of forensic audit with comments of the management, if any, as per regulations, says a notification to the exchange

Amrutanjan initiates forensic audit after whistleblower complaint on lapses involving senior employees

Amrutanjan shares fall 8.15% as company initiates forensic investigation to probe allegation of lapses by some employees

Stocks to watch out for are Amrutanjan, LT Foods, Vodafone Idea, Paytm, and Phoenix Mills

Stocks that will see action on February 15, 2023

Stocks to watch: Titan, CIpla, Wipro, Amrutanjan, Chochin Shipyard, Indigo, Shipping Corp, Chemplast Sanmar, City Union Bank, Dreamfolks Services, Escorts Kubota, GAIL India, Go Fashion (India), Godrej Agro, Marico, Puravankara, TTK Prestiege, TVS Motor Company and Wockhardt

Stocks that will see action on November 04, 2022

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Amrutanjan Health Care Limited is engaged in offering ayurvedic balm for headaches, cold and cough. The Company operates through three segments: over-the-counter (OTC) products, beverages and others.